As of 18 Sept 2026, Jeevan Scientific Technology Ltd share price is ₹80.56. The stock opened at ₹80.56 and had closed at ₹79.71 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹32.85 and a high of ₹93.90. In terms of performance, Jeevan Scientific Technology Ltd share price has increased by 26.52% over the past six months and has increased by 106.56% over the last year.
Jeevan Scienti. Stock Price Chart
Jeevan Scientific Technology Ltd Overview
About Jeevan Scienti.
Jeevan Scientific Tech. is to carry on the business Clinical research, Data management services. Jeevan Scientific is an Independent Clinical Contract Research Organization, offering reliable, cost-effective and technology-driven clinical research solutions to various Clients across the globe.
Jeevan Scientific Technology Ltd Historical Performance
Jeevan Scientific Technology Ltd Fundamentals
Jeevan Scientific Technology Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 55.12 | 44.24 | 39.19 | 37.24 | 62.46 |
| EBITDA | 9.67 | 7.10 | 5.05 | 2.35 | 22.99 |
| Net Profit | 1.65 | 0.74 | -1.05 | -3.00 | 12.26 |
| EPS | 0.83 | 0.47 | -0.68 | -1.96 | 8.15 |
Jeevan Scientific Technology Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 79.62 |
| Resistance 1 (R1) | 83.01 |
| Pivot Point | 81.64 |
Jeevan Scientific Technology Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 21-Sep-2022 | 30-May-2022 | 23-Sep-2022 | Final | ₹1.20 |
| 07-Sep-2021 | 23-Jun-2021 | 08-Sep-2021 | Final | ₹0.50 |
Jeevan Scientific Technology Ltd Key Leadership Details
Last Updated: Mar 2025
| Name | Position |
|---|---|
| Divakar Atluri | Chairman |
| K Krishna Kishore | Vice Chairman & M.D. |
| Snigdha Mothukuri | Chief Executive Officer |
Jeevan Scientific Technology Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Apollo Hospitals Enterprise LtdAPOLLOHOSP | ₹8,696.50-0.20% | ₹1,10,231.07 | 59.08 | 20.48% |
| Max Healthcare Institute LtdMAXHEALTH | ₹1,025.00-0.49% | ₹1,02,534.79 | 72.27 | 13.42% |
| Fortis Healthcare LtdFORTIS | ₹870.30-1.11% | ₹68,746.49 | 70.10 | 10.53% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Jeevan Scientific Technology Ltd today is ₹80.56 on NSE and ₹80.56 on BSE.
- The 52-week high of Jeevan Scientific Technology Ltd is ₹93.90, while the 52-week low is ₹32.85.
- The current market capitalisation of Jeevan Scientific Technology Ltd is approximately ₹160 crore.
- The P/E (Price-to-Earnings) ratio of Jeevan Scientific Technology Ltd is -64.91. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Jeevan Scientific Technology Ltd is 2.12. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Jeevan Scientific Technology Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for Jeevan Scienti. on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Jeevan Scientific Technology Ltd has delivered a return of approximately 30.71%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Jeevan Scientific Technology Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 30.25% promoters, 0.00% FIIs, 0.00% DIIs, and 55.80% public shareholders.

